Aprogen KIC Obtains U.S. Patent for Antibody Treatment of Acute Leukemia
[Asia Economy Reporter Oh Ju-yeon] Aprogen KIC announced on the 12th that it has acquired a U.S. patent for an antibody for the treatment of acute leukemia. Regarding plans to utilize the patent, the company stated, "Once the development of the bispecific antibody applying the dual antibody technology of its affiliate, Aprogen Co., Ltd., to this patent is completed, mass production will be carried out at Aprogen Biologics Osong plant. Aprogen will supply the product to advanced markets through global pharmaceutical companies, while Aprogen Pharmaceutical will be responsible for sales in domestic and overseas emerging markets."
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
